Fluoroestradiol F-18: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Fluoroestradiol F-18. Educational only — not medical advice.
Labeled uses
CERIANNA is indicated for use with positron emission tomography (PET) imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.
Source: FDA labeling via NIH DailyMed (set b2c2a2df…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.